Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

This publication has 42 references indexed in Scilit:

• Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
  Circulation, 2012
• Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
  New England Journal of Medicine, 2010
• Three-Year Survival Following Multivessel Percutaneous Coronary Intervention With Bare-Metal or Drug-Eluting Stents in Unselected Patients
  The American Journal of Cardiology, 2009
• Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation
  The American Journal of Cardiology, 2008
• Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and Prognosis
  Journal of the American College of Cardiology, 2008
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'
  Thrombosis and Haemostasis, 2008
• Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 2007
• Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
  European Heart Journal, 2007
• Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation
  American Heart Journal, 2004
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993